Results 51 to 60 of about 177,811 (299)
Targets for the MalI repressor at the divergent Escherichia coliK-12malX-malI promoters [PDF]
, 2010 Random mutagenesis has been used to identify the target DNA sites for the MalI repressor at the divergent Escherichia coli K-12 malX-malI promoters. The malX promoter is repressed by MalI binding to a DNA site located from position -24 to position -9 ...
Barnard +22 more
core +1 more source
Detection of 5 kinds of common foodborne pathogens by GeXP multiplex polymerase chain reaction
Zhongguo shipin weisheng zazhi, 2020 Objective To establish a new and rapid GeXP (GenomeLabTM eXpress Profiling) based multiplex polymerase chain reaction (PCR) assay for the detection of five common foodborne pathogens. Methods Nucleotide sequences of specific gene (invA, rfbE, PfrA, IpaH,
Mengjie YANG +3 more
doaj +1 more source
Zhongguo shipin weisheng zazhi, 2020 Objective To study the epidemiologic and etiologic characteristics of Salmonella, Shigella, Vibrio parahemolyticus, diarrheagenic Escherichia coli (DEC) from foodborne diarrhea patients in Baiyin.
Meiji LI +7 more
doaj +1 more source
The T3SS of Shigella: Expression, Structure, Function, and Role in Vacuole Escape
Microorganisms, 2020 Shigella spp. are one of the leading causes of infectious diarrheal diseases. They are Escherichia coli pathovars that are characterized by the harboring of a large plasmid that encodes most virulence genes, including a type III secretion system (T3SS ...
Waad Bajunaid +7 more
semanticscholar +1 more source
Advanced Science, EarlyView.This study constructed the W1/O/W2 emulsion–based targeted therapy delivery system for ulcerative colitis (UC) utilizing LCC as surfactant for the first time. This multifunctional emulsion offered certain therapeutic advantages for UC, including targeted colonic delivery of active compounds, synergistic modulation of gut microbiota through combined ...
Qian Wu +9 more
wiley +1 more source
Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
Human Vaccines & Immunotherapeutics, 2020 The development, clinical advancement and licensure of vaccines, and monitoring of vaccine effectiveness could be expedited and simplified by the ability to measure immunological endpoints that can predict a favorable clinical outcome.
Esther Ndungo, Marcela F. Pasetti
doaj +1 more source
Bacterial outer membrane vesicles and vaccine applications [PDF]
, 2014 Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Acevedo, Reinaldo +10 more
core +2 more sources
Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment
Infection and Drug Resistance, 2019 Shigella spp. are a common cause of diarrheal disease and have remained an important pathogen responsible for increased rates of morbidity and mortality caused by dysentery each year around the globe.
R. Ranjbar, A. Farahani
semanticscholar +1 more source
Animal Research and One Health, EarlyView.We conducted a longitudinal trial across nursery, growing, and finishing phases, showing that phytochemical supplementation as a potential antibiotic alternative reduced potential pathogens and promoted beneficial Lactobacillus amylovorus in the nursery phase, and enriched amino acid and carbohydrate metabolism pathways (prediction) during finishing ...
Ziyu Liu +11 more
wiley +1 more source
Isolation and identification of shigella from children in Kirkuk city and the studying some of the virulence characters invitro [PDF]
Kirkuk Journal of Science, 2015 The study included the isolation and identification of Shigella species from stool and rectal swabs of children less than 13 years suffering acute and bloody diarrhea attended Azadi General and children’s hospital in Kirkuk city, using cultural tests on ...
Sarah S. Ghareeb, Hager A. Shareef
doaj +1 more source